Review Article
Year : 2020 | Volume : 3 | Issue : 2 | Page : 15-17
Mucormycosis - A potential aftermath post-COVID-19: A brief review
Deepti C. Jindal, Varun Jindal, Akshita S. Thakur
Department of Dial Pathology and Microbiology, Bhojia Dental College and Hospital. Shut Baddi, District &Nan, Himachal Pradesh, India, 'Private practitioner, Panchkula, Haryana, India
Address for correspondence:
Dr. Deepti, Department of Dial Pathology and Microbiology, Bhojia Dental College and Hospital. Shut Baddi, District &Nan, Himachal Pradesh, India.
Email: drdeeptigerg08@gmail.com
Abstract
The Coronavirus pandemic and its continued streak along with numerous mutations have put forth a major challenge for the medical fraternity worldwide. Due to a new disease entity with a high infectivity rate and associated fatality. it is proving to be highly challenging by being associated with certain morbidities induced by novel therapeutic protocols. Some of the COVID-I9 treated patients suffer from another fatal infection. mucormycosis. commonly called black fungus and this has posed yet another challenge in fighting the COVID menace. The paper features mucormycosis as a preexisting entity in medical science along with its current hazardous trend with novel coronavirus including its management.
Keywords: COVID-19. diabetes, management. mucormycosis
Financial support and sponsorship
The authors disclosed no funding related to this snick.
Conflicts of interest
The authors certify dim there is no conflict of interest said, any financial organization regarding the material discussed in the manuscript.
How to cite this article: Jindal DG, Jindal V, Thakur AS. Mucormycosis—A potential aftermath post-COVID-19: A brief review. Int J Head Neck Pathol 2020;3:15-7.
